MarketCap
Facebook
X
TelegramQuartalsbericht 2023-Q2
hinzugefügt 16.05.2026
OncoSec Medical Incorporated ROA 2011-2026 | ONCS
ROA Jährlich OncoSec Medical Incorporated
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -156.23 | -80.26 | -141.3 | -101.28 | -129.39 | -140.81 | -17.29 | -19.77 | -10.31 | -31.51 | -27.28 | -66.25 | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -10.31 | -156.23 | -76.81 |
ROA Vierteljährlich OncoSec Medical Incorporated
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -183.72 | -134.62 | -100.28 | -87.34 | -79.86 | -66.92 | -84.41 | -138.01 | -148.43 | -202.03 | -205.03 | -161.94 | -162.18 | -119.09 | -100.65 | -123.38 | -125.03 | -147.75 | -155.77 | -129.4 | -125.09 | -98.72 | -87.11 | -86.32 | -85.6 | -84.81 | -88.01 | -80.75 | -80.3 | -73.04 | -61.26 | -60.28 | -53.48 | -52.5 | -53.16 | -55.17 | -59.8 | -61.81 | -86.53 | -160.89 | -150.63 | -224.98 | -122.78 | 32.19 | -24.84 | 112.47 | 47.01 | 65.46 | -66.25 | 47.8 |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 112.47 | -224.98 | -90.7 |
ROA anderer Aktien in der Pharmaeinzelhändler
| Name | ROA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
FSD Pharma
HUGE
|
-241.53 | - | 5743.5 % | $ 69.7 M |  Canada |
 |
MorphoSys AG
MOR
|
-20.13 | - | 2.43 % | $ 254 M |  Germany |
 |
Happiness Biotech Group Limited
HAPP
|
-22.19 | - | 1.35 % | $ 17.8 M |  China |
 |
AgeX Therapeutics
AGE
|
-275.96 | - | -10.17 % | $ 12.2 K |  USA |
 |
Coherus BioSciences
CHRS
|
65.04 | $ 1.63 | -1.52 % | $ 191 M | USA |
 |
I-Mab
IMAB
|
7.43 | - | - | $ 866 M | China |
 |
Celldex Therapeutics
CLDX
|
-44.38 | $ 31.56 | -0.46 % | $ 2.1 B | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
3.33 | - | - | $ 40.3 B | USA |
 |
Genfit SA
GNFT
|
23.87 | - | 2.54 % | $ 160 B |  France |
 |
Biophytis SA
BPTS
|
-142.36 | - | -13.47 % | $ 169 M | France |
 |
BioNTech SE
BNTX
|
-5.17 | $ 97.32 | 4.15 % | $ 23.5 B | Germany |
 |
AstraZeneca PLC
AZN
|
8.97 | - | - | $ 96.9 B |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-53.39 | - | -1.52 % | $ 24.7 M | USA |
 |
CRISPR Therapeutics AG
CRSP
|
-25.67 | $ 55.88 | -0.89 % | $ 5.03 B |  Schweiz |
 |
Athira Pharma
ATHA
|
-114.6 | - | - | $ 269 M | USA |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
-40.14 | - | 0.74 % | $ 768 M |  Israel |
 |
Compugen Ltd.
CGEN
|
22.57 | $ 2.69 | -3.24 % | $ 251 M | Israel |
 |
Abcam plc
ABCM
|
-0.8 | - | - | $ 4.9 B | Britain |
 |
Galera Therapeutics
GRTX
|
2071.28 | - | -32.59 % | $ 7.61 M | USA |
 |
Midatech Pharma plc
MTP
|
-35.12 | - | -18.52 % | $ 27.3 M | Britain |
|
Enlivex Therapeutics Ltd.
ENLV
|
53.1 | $ 0.81 | 5.68 % | $ 37 M | Israel |
 |
Esperion Therapeutics
ESPR
|
-4.87 | $ 3.14 | 0.16 % | $ 653 M | USA |
 |
Affimed N.V.
AFMD
|
-109.04 | - | -34.95 % | $ 21.5 M | Germany |
 |
Eton Pharmaceuticals
ETON
|
-4.99 | $ 30.51 | -4.24 % | $ 821 M | USA |
|
Forte Biosciences
FBRX
|
-83.81 | $ 19.44 | -6.4 % | $ 252 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
4.82 | - | - | - |  Russia |
 |
Checkmate Pharmaceuticals
CMPI
|
-77.89 | - | - | $ 231 M | USA |
 |
Celyad Oncology SA
CYAD
|
-207.62 | - | - | $ 12.5 M |  Belgium |
 |
Berkeley Lights
BLI
|
-43.36 | - | -7.31 % | $ 87 M | USA |
 |
Galectin Therapeutics
GALT
|
-157.87 | $ 2.53 | -1.56 % | $ 162 M | USA |
 |
Generation Bio Co.
GBIO
|
-56.95 | - | - | $ 344 M | USA |
 |
IMV
IMV
|
-121.19 | - | - | $ 13.1 M | Canada |
 |
Akero Therapeutics
AKRO
|
-30.52 | - | - | $ 3.67 B | USA |
 |
Akouos
AKUS
|
-31.09 | - | 0.23 % | $ 488 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
-489.29 | - | - | $ 7.46 M | Israel |
 |
Grifols, S.A.
GRFS
|
0.99 | $ 7.9 | -1.0 % | $ 5.37 B |  Spain |
 |
Hutchison China MediTech Limited
HCM
|
26.06 | $ 11.45 | 1.96 % | $ 9.83 B | China |
 |
Cyclacel Pharmaceuticals
CYCCP
|
36.63 | - | -4.36 % | $ 27 M | USA |
 |
Freeline Therapeutics Holdings plc
FRLN
|
-102.69 | - | - | $ 384 M | Britain |
 |
Gracell Biotechnologies
GRCL
|
-36.68 | - | - | $ 3.37 B | China |
 |
Heron Therapeutics
HRTX
|
-7.82 | $ 0.86 | -3.79 % | $ 143 M | USA |
 |
ImmuCell Corporation
ICCC
|
-2.45 | $ 9.97 | 0.66 % | $ 90 M | USA |
 |
Anika Therapeutics
ANIK
|
-5.72 | $ 14.77 | -0.91 % | $ 212 M | USA |
 |
Advaxis
ADXS
|
-289.96 | - | -9.65 % | $ 45.9 M | USA |
 |
Aeterna Zentaris
AEZS
|
-48.33 | - | 5.93 % | $ 314 M | Canada |
 |
Aeglea BioTherapeutics
AGLE
|
-19.95 | - | - | $ 1.01 B | USA |
 |
CureVac N.V.
CVAC
|
-35.55 | - | - | $ 867 M | Germany |
 |
Applied Genetic Technologies Corporation
AGTC
|
-27.57 | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
-19.87 | - | 1.93 % | $ 17.4 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-103.3 | $ 3.36 | - | $ 5.53 M | Israel |